Waters Corporation WAT
Composite 41/100; the shares have moved about 38% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 18/100 — a strong mark against it.
Momentum ranks 73/100 — a moderate point in its favour. Balance-sheet strength ranks 57/100 — a slight point in its favour.
Valuation ranks 18/100 — a strong mark against it. Quality ranks 29/100 — a moderate mark against it. Growth ranks 37/100 — a moderate mark against it.
What the company does Waters Corporation designs, manufactures, and services liquid chromatography and mass spectrometry systems used in drug discovery, clinical testing, environmental analysis, and life sciences research.
Key financials Waters reports gross margins of 56.3% and operating margins of 10.0%, but net margins are thin at 3.6%. Revenue growth is strong at 113.3%, though EPS growth is negative at -3.1%. Profitability metrics like ROE (1.9%) and ROA (3.5%) are weak.
Stock health Momentum is robust with 3m/6m/12m gains of 23.46%, 25.61%, and 44.83%, respectively. RSI(14) at 68.50 signals overbought conditions, and the stock is -1.60% below its 52-week high.
Price vs fair value The stock trades at a **discount of 4.80%** versus the analyst mean target of 433.39. - Analysts highlight competitive advantages in Q2 earnings call (Motley Fool). - Recent coverage emphasizes Waters’ growth potential (StockStory). - MarketBeat notes strong Q2 earnings call highlights. - StockStory flags it as a surging stock with competitive moats.
Looking forward Forward P/E of 27.70 and PEG of 0.10 suggest expectations for earnings growth, but thin margins and weak ROE temper enthusiasm. Momentum remains a key driver.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.